1. Home
  2. ADTX vs SOPA Comparison

ADTX vs SOPA Comparison

Compare ADTX & SOPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADTX
  • SOPA
  • Stock Information
  • Founded
  • ADTX 2017
  • SOPA 2018
  • Country
  • ADTX United States
  • SOPA Singapore
  • Employees
  • ADTX N/A
  • SOPA N/A
  • Industry
  • ADTX Biotechnology: Pharmaceutical Preparations
  • SOPA EDP Services
  • Sector
  • ADTX Health Care
  • SOPA Technology
  • Exchange
  • ADTX Nasdaq
  • SOPA Nasdaq
  • Market Cap
  • ADTX 5.3M
  • SOPA 6.3M
  • IPO Year
  • ADTX 2020
  • SOPA 2021
  • Fundamental
  • Price
  • ADTX $5.00
  • SOPA $0.82
  • Analyst Decision
  • ADTX
  • SOPA Buy
  • Analyst Count
  • ADTX 0
  • SOPA 2
  • Target Price
  • ADTX N/A
  • SOPA $16.00
  • AVG Volume (30 Days)
  • ADTX 8.1M
  • SOPA 77.5K
  • Earning Date
  • ADTX 05-19-2025
  • SOPA 05-14-2025
  • Dividend Yield
  • ADTX N/A
  • SOPA N/A
  • EPS Growth
  • ADTX N/A
  • SOPA N/A
  • EPS
  • ADTX N/A
  • SOPA N/A
  • Revenue
  • ADTX $133,985.00
  • SOPA $6,906,240.00
  • Revenue This Year
  • ADTX $95.61
  • SOPA $7.97
  • Revenue Next Year
  • ADTX $1,584.79
  • SOPA $15.61
  • P/E Ratio
  • ADTX N/A
  • SOPA N/A
  • Revenue Growth
  • ADTX N/A
  • SOPA N/A
  • 52 Week Low
  • ADTX $4.11
  • SOPA $0.73
  • 52 Week High
  • ADTX $35,000.00
  • SOPA $6.75
  • Technical
  • Relative Strength Index (RSI)
  • ADTX 33.28
  • SOPA 34.46
  • Support Level
  • ADTX $4.17
  • SOPA $1.10
  • Resistance Level
  • ADTX $7.69
  • SOPA $1.18
  • Average True Range (ATR)
  • ADTX 1.92
  • SOPA 0.08
  • MACD
  • ADTX 0.36
  • SOPA -0.01
  • Stochastic Oscillator
  • ADTX 10.10
  • SOPA 3.61

About ADTX Aditxt Inc.

Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics the way bodies naturally induce tolerance to tissues.

About SOPA Society Pass Incorporated

Society Pass Inc is building an ecosystem of platforms and technology-enabled companies that synergistically work together to transform how consumers and merchants interact with one another in Southeast Asia and South Asia. Through the acquisition of companies and partnerships with visionary entrepreneurs, the company meets the growing demand for better services in sectors such as lifestyle, beauty, travel, and food and beverage. The company currently operates in Six reportable operating segments: Online Grocery and Food and grocery deliveries, Digital marketing, Online ticketing and reservation, Telecommunications Reseller, e-commerce, and Merchant Point of Sale (merchant POS). The company generates the majority of its revenue from the Digital marketing segment.

Share on Social Networks: